Bristol-Myers Squibb (BMY) Tops Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $61.89 -0.58%
Revenue Growth %: +3.2%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +3.2%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $1.83, $0.01 better than the analyst estimate of $1.82. Revenue for the quarter came in at $12 billion versus the consensus estimate of $12.12 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2022 EPS of $7.65-$7.95.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Scotiabank Reiterates Sector Outperform Rating on Ero Copper Corp. (ERO:CN) (ERO)
- KB Home (KBH) PT Lowered to $50 at RBC Capital
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
